CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
61.74
+6.54 (11.85%)
At close: Feb 26, 2026, 4:00 PM EST
61.00
-0.74 (-1.20%)
After-hours: Feb 26, 2026, 4:45 PM EST
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $5.93 billion as of February 26, 2026. Its market cap has increased by 76.17% in one year.
Market Cap
5.93B
Enterprise Value
3.95B
1-Year Change
76.17%
Ranking
Category
Stock Price
$61.74
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $5.93B, an increase of 958.05%. That is a compound annual growth rate of 28.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 5.30B | 6.02% |
| Dec 31, 2025 | 5.00B | 48.76% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cogent Biosciences | 5.97B |
| PTC Therapeutics | 5.84B |
| Immunovant | 5.54B |
| Protagonist Therapeutics | 5.41B |
| Caris Life Sciences | 4.98B |
| Celcuity | 4.87B |
| Scholar Rock Holding | 4.80B |
| Apogee Therapeutics | 4.72B |